Lehr Donald P. 4
Research Summary
AI-generated summary
Precigen (PGEN) CLO Donald Lehr Receives 465,000-Share Award
What Happened
- Donald P. Lehr, Chief Legal Officer of Precigen (PGEN), received two compensation awards on 2026-04-20: 358,000 stock option awards and 107,000 restricted stock units (RSUs), totaling 465,000 derivative shares. Both grants are reported as "A" (award/grant) on the Form 4 and show $0 acquisition price because they are compensation awards, not open-market purchases.
Key Details
- Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (filed within the SEC two-business-day window).
- Grant details:
- 358,000 options (derivative) — vesting: 25% on May 23, 2027, then equal monthly installments over the following three years (footnote F1).
- 107,000 RSUs — each RSU equals a contingent right to one share; vesting: 25% on May 23, 2027, then equal six-month installments over the next three years (footnotes F2-F3).
- Reported price: $0.00 for both grants (standard for awards; not a cash purchase).
- Shares owned after the transaction: not specified in the filing.
Context
- These are compensation grants (options + RSUs), not market purchases or sales; they represent future rights to shares conditional on vesting and employment.
- For retail investors: awards signal internal compensation/retention activity but are not an immediate bullish purchase of shares. No exercise or sale occurred in this filing.